Worldquant has reduced its short position in the pharmaceutical company Hansa Biopharma below the threshold and is therefore no longer a disclosed short seller in the company.
There are now two disclosed short sellers in the company. In total, 5.23 percent of the capital in Hansa Biopharma is shorted.
The Swedish Financial Supervisory Authority requires positions above 0.1 percent to be reported, and short positions above 0.5 percent to be disclosed publicly.
